Why Is Glenmark Pharma' Showing Short-Term Weakness Despite a Strong Long-Term Trend?
About Glenmark Pharmaceuticals
Glenmark Pharmaceuticals Limited, a diversified pharmaceutical major, has drawn trader attention after breaching its rising channel support. The pattern indicates a pause or moderation in the otherwise healthy long-term uptrend. While short-term volatility persists, the medium-term structure continues to signal underlying strength.
Technically, Glenmark has broken below the floor of a medium-term rising channel, hinting at a slower upward pace or potential sideways movement. This phase often precedes a consolidation band before resuming the larger trend.
The counter shows support near ₹1640 and resistance around ₹2220. Positive volume balance, where buying volumes dominate, suggests accumulation. However, a falling RSI curve warns that a brief dip cannot be ruled out. Traders may consider waiting for confirmation candles before re-entry.
For intraday setups and tactical positions, refer to our Nifty Intraday Advice for calibrated momentum alignment with daily signals.
According to Indian-Share-Tips.com Technical Analyst Gulshan Khera, CFP®, who is also a SEBI Registered Investment Adviser, “Glenmark remains a fundamentally sound counter. The short-term correction reflects profit booking within a healthy structure. Sustained strength above ₹1700 can revive the medium-term uptrend.”
Investor Takeaway
- ✅ Support seen near ₹1640 with a positive long-term bias.
- 💡 RSI weakness offers re-entry opportunity on dips.
- 🎯 Stock remains medium-term positive despite short-term pressure.
Related Queries
- Why Does RSI Divergence Signal Possible Rebound for Glenmark?
- What Key Levels Should Traders Watch in Glenmark’s Consolidation Phase?
SEBI Disclaimer: The information provided in this post is for informational purposes only and should not be construed as investment advice. Readers must perform their own due diligence and consult a registered investment advisor before making any investment decisions. The views expressed are general in nature and may not suit individual investment objectives or financial situations.
